AKT1 and glioblastoma: Our data proposed HMGN5 as a critical molecule which is involved in the regulation of malignant behavior as well as in the PI3K/AKT and MAPK pathway in GBM cells, suggesting that this protein might be a possible target for glioblastoma-targeted therapy.